18th CANDIAN MELANOMA CONFERENCE 2024: Pfizer Lunch Symposium: Bridging the Evidence Gap for Targeted Therapy Usein BRAF V600 Metastatic Melanoma: Reconciling Clinical Trial Data and RealWorld Evidence to Optimize Clinical Care – Prof. Caroline Robert

18th CANDIAN MELANOMA CONFERENCE 2024: Pfizer Lunch Symposium: Bridging the Evidence Gap for Targeted Therapy Usein BRAF V600 Metastatic Melanoma: Reconciling Clinical Trial Data and RealWorld Evidence to Optimize Clinical Care – Prof. Caroline Robert

Canadian Melanoma Conference 2024
Icon Objectives

Learning Objectives

  1. Describe key clinical trial data from 2023 in the management of melanoma and understand the impact on Canadian practices.
  2. Understand the latest strategies in melanoma as they pertain to medical oncology, pathology, radiation, and surgery.
  3. Implement approaches that maximize patient standard of care in melanoma
Icon Chair Speaker

Co-Chairs

Dr. Vanessa Bernstein
Dr. Teresa Petrella

Icon Chair Speaker

Speakers

Prof. Caroline Robert

This program has been made possible through unrestricted support from Pfizer

Tagged